Kodiak Sciences Announces Recent Business Highlights and First Quarter 2025 Financial Results
PALO ALTO, Calif., May 14, 2025 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the... Read more.
Caldera Launches New Subscription Package for the Visual Communications, Industrial Printing and Packaging Industry
DOWNERS GROVE, Ill., May 14, 2025 /PRNewswire/ — Caldera, part of Dover (NYSE: DOV), today announced the launch of GrandRIP, a new subscription raster image... Read more.
Perrone Robotics Announces Formation of Dedicated Transit Division to Support Growth and Enhanced Customer Focus
CHARLOTTESVILLE, Va., May 14, 2025 /PRNewswire/ — Perrone Robotics, Inc., a pioneer and leader in autonomous vehicle technology, today announced the establishment... Read more.
Canaan Inc. Provides April 2025 Bitcoin Production and Mining Operation Updates
SINGAPORE, May 14, 2025 /PRNewswire/ — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), an innovator in crypto mining, today... Read more.
MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
Marpai’s turnaround momentum is building TAMPA, Fla., May 14, 2025 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (OTCQX:... Read more.
Precigen Reports First Quarter 2025 Financial Results and Business Updates
PRGN-2012 has the potential to be the first- and best-in-class treatment for RRP Company’s BLA for PRGN-2012 for the treatment of adults with RRP is under... Read more.
Inhibrx Reports First Quarter 2025 Financial Results
SAN DIEGO, May 14, 2025 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”) today reported financial... Read more.
FG Merger II Corp. Announces Reduction on Permitted Working Capital Withdrawals from Trust Account
ITASCA, Ill., May 14, 2025 /PRNewswire/ — FG Merger II Corp. (the “Company“), a newly organized blank check company formed as a Nevada corporation,... Read more.
CoreWeave Reports Strong First Quarter 2025 Results
Growth Driven by Accelerating Demand for CoreWeave’s Purpose-built AI Platform LIVINGSTON, N.J., May 14, 2025 /PRNewswire/ — CoreWeave, Inc. (Nasdaq:... Read more.
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
Updated data from the Phase 1 ENABLE clinical trial of ELVN-001 in CML to be presented at the EHA 2025 Congress in June EHA abstract reported cumulative MMR rate... Read more.